Obesity and Cardiovascular Disease: Weight Loss Is Not the Only Target

Canadian Journal of Cardiology

Volumn 31, Issue 2, 2015, Pages 216-222

  Després, Jean Pierre ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BODY BUILD; BODY FAT DISTRIBUTION; BODY MASS; BODY WEIGHT; CALORIC RESTRICTION; CARDIORESPIRATORY FITNESS; CARDIOVASCULAR DISEASE; ENDURANCE TRAINING; HUMAN; INTRAABDOMINAL FAT; LIFESTYLE MODIFICATION; NUTRITIONAL VALUE; OBESITY; PHYSICAL ACTIVITY; SEDENTARY LIFESTYLE; WAIST CIRCUMFERENCE; WEIGHT REDUCTION; CARDIOVASCULAR DISEASES; COMPLICATION; FITNESS; HEALTH STATUS;

BODY MASS INDEX; CARDIOVASCULAR DISEASES; HEALTH STATUS; HUMANS; OBESITY; PHYSICAL FITNESS; WEIGHT LOSS;

EID: 84925016724     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2014.12.009     Document Type: Article

References (36)

1. Zimmet P., Alberti K.G., Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001, 414:782-787.
2. Xu Y., Wang L., He J., et al. Prevalence and control of diabetes in Chinese adults. JAMA 2013, 310:948-959.
3. Calle E.E., Rodriguez C., Walker-Thurmond K., Thun M.J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. NEngl J Med 2003, 348:1625-1638.
4. Poirier P., Giles T.D., Bray G.A., et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006, 113:898-918.
5. Keys A., Fidanza F., Karvonen M.J., Kimura N., Taylor H.L. Indices of relative weight and obesity. JChronic Dis 1972, 25:329-343.
6. Flegal K.M., Kit B.K., Orpana H., Graubard B.I. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 2013, 309:71-82.
7. Heymsfield S.B., Cefalu W.T. Does body mass index adequately convey a patient's mortality risk?. JAMA 2013, 309:87-88.
8. Pischon T., Boeing H., Hoffmann K., et al. General and abdominal adiposity and risk of death in Europe. NEngl J Med 2008, 359:2105-2120.
9. Keith S.W., Fontaine K.R., Allison D.B. Mortality rate and overweight: overblown or underestimated? A commentary on a recent meta-analysis of the associations of BMI and mortality. Mol Metab 2013, 2:65-68.
10. Wormser D., Kaptoge S., Di Angelantonio E., et al. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet 2011, 377:1085-1095.
11. Després J.P. Body fat distribution and risk of cardiovascular disease: an update. Circulation 2012, 126:1301-1313.
12. Tchernof A., Després J.P. Pathophysiology of human visceral obesity: an update. Physiol Rev 2013, 93:359-404.
13. Després J.P., Moorjani S., Lupien P.J., et al. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis 1990, 10:497-511.
14. Després J.P., Ross R., Lemieux S. Imaging techniques applied to the measurement of human body composition. Human Body Composition 1996, 149-166. Human Kinetics, Champaign, IL. A.F. Roche, S.B. Heymsfield, T.G. Lohman (Eds.).
15. Preis S.R., Massaro J.M., Robins S.J., et al. Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham Heart Study. Obesity (Silver Spring) 2010, 18:2191-2198.
16. Neeland I.J., Ayers C.R., Rohatgi A.K., et al. Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults. Obesity (Silver Spring) 2013, 21:E439-E447.
17. Liu J., Fox C.S., Hickson D.A., et al. Impact of abdominal visceral and subcutaneous adipose tissue on cardiometabolic risk factors: the Jackson Heart Study. JClin Endocrinol Metab 2010, 95:5419-5426.
18. Smith J.D., Borel A.L., Nazare J.A., et al. Visceral adipose tissue indicates the severity of cardiometabolic risk in patients with and without type 2diabetes: results from the INSPIRE ME IAA study. JClin Endocrinol Metab 2012, 97:1517-1525.
19. Smith J., Nazare J.A., Borel A.L., et al. Assessment of cardiometabolic risk and prevalence of meeting treatment guidelines among patients with type 2 diabetes stratified according to their use of insulin and/or other diabetic medications: results from INSPIRE ME IAA. Diabetes Obes Metab 2013, 15:629-641.
20. Neeland I.J., Turer A.T., Ayers C.R., et al. Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA 2012, 308:1150-1159.
21. Bays H.E. Adiposopathy is "sick fat" a cardiovascular disease?. JAm Coll Cardiol 2011, 57:2461-2473.
22. Britton K.A., Fox C.S. Ectopic fat depots and cardiovascular disease. Circulation 2011, 124:e837-e841.
23. Look AHEAD Research Group, Wing R.R., Bolin P., et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. NEngl J Med 2013, 369:145-154.
24. Lloyd-Jones D.M., Hong Y., Labarthe D., et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation 2010, 121:586-613.
25. Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol 2014, 2:801-809. Look AHEAD Research Group.
26. Rubin R.R., Wadden T.A., Bahnson J.L., et al. Impact of intensive lifestyle intervention on depression and health-related quality of life in type 2diabetes: the Look AHEAD Trial. Diabetes Care 2014, 37:1544-1553.
27. Espeland M.A., Glick H.A., Bertoni A., et al. Impact of an intensive lifestyle intervention on use and cost of medical services among overweight and obese adults with type 2 diabetes: the action for health in diabetes. Diabetes Care 2014, 37:2548-2556.
28. Estruch R., Ros E., Salas-Salvado J., et al. Primary prevention of cardiovascular disease with a Mediterranean diet. NEngl J Med 2013, 368:1279-1290.
29. Broekhuizen L.N., Boekholdt S.M., Arsenault B.J., et al. Physical activity, metabolic syndrome, and coronary risk: the EPIC-Norfolk prospective population study. Eur J Cardiovasc Prev Rehabil 2011, 18:209-217.
30. Church T.S., LaMonte M.J., Barlow C.E., Blair S.N. Cardiorespiratory fitness and body mass index as predictors of cardiovascular disease mortality among men with diabetes. Arch Intern Med 2005, 165:2114-2120.
31. Swift D.L., Lavie C.J., Johannsen N.M., et al. Physical activity, cardiorespiratory fitness, and exercise training in primary and secondary coronary prevention. Circ J 2013, 77:281-292.
32. Arsenault B.J., Lachance D., Lemieux I., et al. Visceral adipose tissue accumulation, cardiorespiratory fitness, and features of the metabolic syndrome. Arch Intern Med 2007, 167:1518-1525.
33. Vissers D., Hens W., Taeymans J., et al. The effect of exercise on visceral adipose tissue in overweight adults: a systematic review and meta-analysis. PLoS One 2013, 8:e56415.
34. Fiuza-Luces C., Garatachea N., Berger N.A., Lucia A. Exercise is the real polypill. Physiology 2013, 28:330-358.
35. Jensen M.D., Ryan D.H., Apovian C.M., et al. 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation 2014, 129:S102-S138.
36. Novak N.L., Brownell K.D. Role of policy and government in the obesity epidemic. Circulation 2012, 126:2345-2352.